Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada
  • Published Date:
    Apr 2019
  • Source:
    Emerg Infect Dis. 25(4):838-840
  • Language:
    English
Filetype[PDF-295.88 KB]


Details:
No Related Documents.
You May Also Like:
  1. Coming Soon
    Urinary Metal Mixtures and Longitudinal Changes in Glucose Homeostasis: The Study of Women’s Health Across the Nation (SWAN)
    Personal Author:
    Wang, Xin; Mukherjee, Bhramar; Karvonen-Gutierrez, Carrie A.; Herman, William H.; Batterman, Stuart; Harlow, Siobán D.; Park, Sung Kyun;
    Published Date:
    12/01/2020
    Source:
    Environ Int. 145:106109
    Description:
    Background:Epidemiologic studies on associations between metals and insulin resistance and β-cell dysfunction have been cross-sectional and focused on individual metals.Objective:We assessed the association of exposure to metal mixtures, based on as...
    Public Access
    Available on:
    December 01, 2021
  2. Testing and management considerations for nursing home residents with acute respiratory illness symptoms when SARS-CoV-2 and Influenza viruses are co-circulating
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.)
    Published Date:
    November 23, 2020
    Description:
    The following practices should be considered when SARS-CoV-2 and Influenza viruses are found to be co-circulating based upon local public health surveillance data and testing at local healthcare facilities. While these considerations are specific to ...
    File Type:
    Filetype[PDF - 203.35 KB]
  3. Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending November 14, 2020 (Week 46) Table1kk Vancomycin-resistant Staphylococcus aureus; Varicella morbidity
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    11/19/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 46
    Description:
    2020-46-Table1kk -H.pdf
    File Type:
    Filetype[PDF - 118.56 KB]
  4. Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending November 14, 2020 (Week 46) Table1jj Tularemia; Vancomycin-intermediate Staphylococcus aureus
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    11/19/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 46
    Description:
    2020-46-Table1jj -H.pdf
    File Type:
    Filetype[PDF - 98.98 KB]
  5. Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending November 7, 2020 (Week 45) Table1kk Vancomycin-resistant Staphylococcus aureus; Varicella morbidity
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    11/13/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 45
    Description:
    2020-45-Table1kk -H.pdf
    File Type:
    Filetype[PDF - 118.49 KB]